No Data
現代中藥集團:2023年報
Futu News06:07 ET · Announcements
Tong Ren Tang Chinese Medicine (03613): Issued a certificate of registration for proprietary Chinese medicines
According to Zhitong Finance App, Tong Ren Tang Sinopharm (03613) issued an announcement. The company recently received the “Certificate of Registration for Proprietary Chinese Medicines” issued by the Hong Kong Traditional Chinese Medicine Administration, which allows the sale of “Angelica Blood Supplementation Granules [Tong Ren Tang]” in Hong Kong.
Zhitong Finance06:06 ET
Tong Ren Tang (600085.SH): “Angelica Blood Supplement Granules [Tong Ren Tang]” obtained the Hong Kong Proprietary Chinese Medicine Registration Certificate
Zhitong Finance App News, Tong Ren Tang (600085.SH) issued an announcement. Recently, Beijing Tongrentang Sinopharm Co., Ltd. (hereinafter referred to as Tongrentang Sinopharm), the company's holding company, received the “Certificate of Registration for Proprietary Chinese Medicine” issued by the Hong Kong Traditional Chinese Medicine Administration, permitting the sale of “Angelica Blood Supplement Granules [Tong Ren Tang]” in Hong Kong. According to the announcement, after receiving the registration certificate for proprietary Chinese medicines issued by the Hong Kong Traditional Chinese Medicine Administration, Tongrentang Sinopharm's angelica blood supplement granules “Tong Ren Tang” can be sold in Hong Kong, which will help enrich its product line and facilitate its market expansion. The one with the above registration certificate
Zhitong Finance04:25 ET
康臣葯業:股東周年大會通告
Futu News18:32 ET · Announcements
康臣葯業:2023 年度報告
Futu News18:29 ET · Announcements
綠葉製藥:年報 2023
Futu NewsApr 29 10:54 ET · Announcements